Skip to main content
    T

    Trevi Therapeutics Inc (TRVI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $13.51
    +0.22 (+1.66%)

    Market Cap: $1.89B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Trevi Therapeutics Inc (TRVI) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Trevi Therapeutics (TRVI) has a latest price of $13.51 on Nov 17, 2026, 33.2% below its 52-week high of $20.22. Its price rose 18.8% over the past 12 months. The month-end price rose 1,054.0% over the 5 years through Oct 2026, a compound annual rate of 63.1%.

    Price Chart

    From May 2019 to Oct 2026, its highest month-end close was $18.65 in Jun 2026 and its lowest $0.64 in Jan 2022, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart TRVI with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TRVI.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 28.2%, and over 6 months it rose 2.0%. The month-end price rose 661.8% over the 3 years through Oct 2026, a compound annual rate of 96.8%.

    PeriodChange
    1 month+13.5%
    3 months-28.2%
    6 months+2.0%
    12 months+18.8%
    12 months, with dividends+18.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+661.8%+96.8%
    5 years+1,054.0%+63.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 207.5%, and its weakest was 2021, when it fell 67.7%.

    YearCloseChange
    2026 through Oct 2026$13.56+8.3%
    2025$12.52+203.9%
    2024$4.12+207.5%
    2023$1.34-30.6%
    2022$1.93+146.7%
    2021$0.78-67.7%
    2020$2.42-35.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 2.7% below its 50-day average of $13.89 and 7.1% below its 200-day average of $14.55.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$13.51
    52-week high$20.22-33.2%
    52-week low$9.82+37.6%
    50-day average$13.89-2.7%
    200-day average$14.55-7.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 39.1%.

    MeasureValue
    1-year beta1.37
    Largest fall, 1 year-39.1%
    Largest fall, 3 years-39.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About TRVI

    What is TRVI's 1-year price change?

    Trevi Therapeutics's price rose 18.8% over the past 12 months. With dividends included, the 12-month total return was 18.8%.

    What is TRVI's 5-year price change?

    Trevi Therapeutics's month-end price rose 1,054.0% over the 5 years through Oct 2026, a compound annual rate of 63.1%. These figures leave out dividends.

    What is TRVI's 52-week high and low?

    Trevi Therapeutics's 52-week high is $20.22 and its 52-week low is $9.82. Its latest price of $13.51 on Nov 17, 2026 is 33.2% below the high.

    What is TRVI's beta?

    Trevi Therapeutics's 1-year beta against the S&P 500 is 1.37, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 39.1%.

    Is the TRVI chart free?

    Yes. Advanced Charting for TRVI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.